Regeneron Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
23.09.24
/
50%
€995.60
Target price
23.09.25
€1,078.7
Performance (%)
-51.79%
End price
24.09.25
€480.00
Summary
This prediction ended on 24.09.25 with a price of €480.00. The BUY prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -51.79%. Wells_Fargo___Compan has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €2.60 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.423% | 3.423% | 17.355% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $1,200.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€519.00
30.04.25
30.04.25
€615.65
30.04.26
30.04.26
29.94%
01.04.26
01.04.26
Stopped prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€693.60
10.01.25
10.01.25
€875.97
10.01.26
10.01.26
-1.53%
11.01.26
11.01.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€992.60
02.08.24
02.08.24
€1,099.3
02.08.25
02.08.25
-51.42%
03.08.25
03.08.25